Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Nature Communications|March 3, 2025
Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbiditiesDouglas P Loesch, Manik Garg, Dorota Matelska, et al.
Chronobiology International|July 11, 2013
Impact of seasonality on the prevalence of dyslipidemia: a large population studyFilipe A Moura, Marcelo S Dutra-Rodrigues, Angela S Cassol, et al.
Circulation|March 30, 2026
Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging StudyNicholas A Marston, Brian A Bergmark, Thomas A Prohaska, et al.
Circulation. Heart Failure|May 14, 2025
Detection of Hypertrophic Cardiomyopathy on Electrocardiogram Using Artificial IntelligenceJames M Hillis, Bernardo C Bizzo, Sarah F Mercaldo, et al.
Nature Medicine|September 25, 2025
Antibody-mediated LOX-1 inhibition in patients with residual inflammation after myocardial infarction: a randomized phase 2 trialMichelle L O'Donoghue, David A Morrow, Andrea L Vavere, et al.
The New England Journal of Medicine|November 10, 2025
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis RiskNicholas A Marston, Brian A Bergmark, Veronica J Alexander, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Common genetic variants near SLC2A2 and glycemic response to glimepiride in the GRADE comparative effectiveness clinical trialJosephine H Li, Lukasz Szczerbinski, Mark Tripputi, et al.
Frontiers in Pharmacology|October 22, 2024
Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational studyHelison R P Carmo, Alejandro Rossel Castillo, Isabella Bonilha, et al.
Nature|February 19, 2024
Genetic drivers of heterogeneity in type 2 diabetes pathophysiologyKen Suzuki, Konstantinos Hatzikotoulas, Lorraine Southam, et al.
Pageof 5